5α-Reductase Isozymes in the Prostate

Area of Science:

• Biochemistry
• Endocrinology
• Genetics

Background:

• 5α-reductases (types 1 and 2) convert testosterone to dihydrotestosterone (DHT).
• Mutations in type 2 5α-reductase cause male pseudohermaphroditism with ambiguous genitalia and underdeveloped prostates.
• Prostate specific antigen (PSA) levels are low in affected individuals, who do not develop prostate cancer or BPH.

Purpose of the Study:

• To explore the role of 5α-reductase isozymes in male sexual differentiation and prostate physiology.
• To investigate the impact of 5α-reductase activity on prostate development and disease.
• To analyze the relationship between testosterone, DHT, and prostate health.

Main Methods:

• Review of genetic mutations in 5α-reductase type 2.
• Analysis of animal models with gene knockouts or inhibitor treatments.
• Examination of factors regulating prostate 5α-reductase-2 gene expression, including dietary fat and genistein.

Main Results:

• Individuals with 5α-reductase type 2 deficiency exhibit high testosterone/DHT ratios, ambiguous genitalia, and rudimentary prostates.
• Animal models lacking 5α-reductase-2 show similar prostate development defects.
• High dietary fat increases prostate 5α-reductase-2 expression, while genistein inhibits it.

Conclusions:

• DHT is crucial for male sexual differentiation and prostate physiology.
• 5α-reductase activity significantly influences prostate development and pathophysiology.
• Inhibition of 5α-reductase is a therapeutic target for BPH and male-pattern baldness, with ongoing research for prostate cancer prevention.